GlassScriptPhysician profile
Irving L Schwartz
NPI 1831103092
$3,895.56
in general payments reported to CMS, 2019-2025
34 companies · $820 in 2025
The $820 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,272 · 2020: $29.32 · 2022: $222 · 2023: $750 · 2024: $803 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,052.74 | 2019-2025 | |
| Boston Scientific Corporation | $365.43 | 2022-2025 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $352.26 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $271.87 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $218.63 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $197.64 | 2019-2025 | Wainua, Brilinta, Farxiga |
| Pfizer INC. | $126.68 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.23 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $97.99 | 2024 | Arcalyst |
| Novo Nordisk INC | $89.70 | 2025 | Wegovy |
| Gilead Sciences, INC. | $87.60 | 2019 | |
| Heartflow, INC. | $74.46 | 2022-2025 | |
| Lundbeck LLC | $70.04 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $68.57 | 2019 | |
| Esperion Therapeutics, INC. | $65.60 | 2025 | Nexletol |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $63.57 | 2024 | Amplatzer Amulet, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.43 | 2019-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $59.49 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $56.27 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $54.24 | 2019-2025 | Amvuttra |
| Medtronic Vascular, INC. | $46.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $45.48 | 2019 | |
| Irhythm Technologies, INC. | $45.07 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Lantheus Medical Imaging, INC. | $29.70 | 2023 | Definity |
| Abiomed | $26.45 | 2024 | Impella |
| Arbor Pharmaceuticals, INC. | $19.36 | 2019 | |
| Biobeat USA INC. | $18.45 | 2024 | Bb-613 Bpm Kit |
| Scpharmaceuticals INC. | $17.98 | 2023 | |
| Inspire Medical Systems, INC. | $17.59 | 2025 | Inspire |
| Medtronic, INC. | $16.48 | 2023 | Linq II |
| Vifor Pharma, INC. | $15.77 | 2019 | |
| Daiichi Sankyo INC. | $13.95 | 2023 | Injectafer |
| Genzyme Corporation | $11.69 | 2019 | |
| Angiodynamics, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irving Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.